Skip to Main Content

Paper Details

Risk Factors With Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy-Reply.
JAMA Neurol
0
2021
Author NameAffiliation
Daniel B RubinMassachusetts General Hospital, Harvard Medical School
Henrikas VaitkeviciusBrigham and Women's Hospital
Henrikas VaitkeviciusNow with Clinical Development, Marinus Pharmaceuticals Inc
  • 1 - 3

Datasets

Release 1.2